Ownership and insider activity for KORU Medical Systems, Inc. (KRMD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems.
Price
| Price | $3.22 |
| Market Cap | $148M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-08 | KALBERMATTEN ADAM R | P-Purchase | 32,000 | $101K |
| 2026-07-28 | KALBERMATTEN ADAM R | M-Exempt | 75,000 | |
| 2026-07-28 | KALBERMATTEN ADAM R | F-InKind | 25,483 | $109K |
| 2026-07-01 | KALBERMATTEN ADAM R | A-Award | 284,091 | |
| 2026-07-01 | KALBERMATTEN ADAM R | A-Award | 286,697 | |
| 2026-07-01 | WHOLIHAN EDWARD | A-Award | 3,571 | $15K |
| 2026-07-01 | Matin Shahriar | A-Award | 3,571 | $15K |
| 2026-07-01 | French Donna | A-Award | 3,571 | $15K |
| 2026-07-01 | FLETCHER R JOHN | A-Award | 5,357 | $22K |
| 2026-07-01 | CASCELLA ROBERT | A-Award | 3,571 | $15K |
Balance Sheet (10y)
| Year | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.3M | $4.0M | $3.7M | $5.9M | $27.3M | $25.3M | $17.4M | $11.5M | $9.6M | $8.9M |
| Short-term Investments | $262314 | $263269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $1.7M | $1.9M | $1.4M | $3.2M | $2.6M | $3.6M | $3.6M | $4.0M | $6.0M | $6.5M |
| Inventory | $1.4M | $1.7M | $2.1M | $2.4M | $6.8M | $6.1M | $6.4M | $3.5M | $2.8M | $3.7M |
| Total Current Assets | $6.8M | $7.9M | $9.0M | $11.9M | $37.5M | $37.3M | $29.8M | $20.3M | $19.1M | $20.0M |
| Property, Plant & Equipment | $932092 | $836283 | $858781 | $985580 | $1.4M | $1.2M | $7.7M | $7.4M | $7.3M | $7.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $426943 | $483821 | $632156 | $807135 | $843587 | $808813 | $787182 | $754361 | $730279 | $684841 |
| Total Assets | $8.2M | $9.3M | $10.5M | $13.9M | $39.9M | $41.3M | $42.3M | $28.5M | $27.2M | $28.2M |
| Accounts Payable | $772428 | $454398 | $453498 | $572656 | $624920 | $1.2M | $2.4M | $975193 | $1.6M | $2.3M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | $508583 | $433295 | $314344 | $271152 | $538361 |
| Total Current Liabilities | $1.4M | $1.6M | $1.6M | $2.4M | $3.7M | $4.8M | $7.0M | $4.5M | $7.2M | $8.2M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.0M |
| Total Liabilities | $1.5M | $1.6M | $1.6M | $2.6M | $3.8M | $4.8M | $11.0M | $8.1M | $10.4M | $11.2M |
| Retained Earnings | $2.5M | $3.4M | $4.3M | $4.9M | $3.7M | -$910069 | -$9.6M | -$23.3M | -$29.4M | -$32.0M |
| Total Equity | $6.7M | $7.7M | $9.0M | $11.2M | $36.2M | $36.5M | $31.3M | $20.4M | $16.8M | $17.0M |
| Total Debt | 0 | 0 | 0 | $381676 | $239492 | $604136 | $4.9M | $4.4M | $4.0M | $3.5M |
| Net Debt | -$3.6M | -$4.2M | -$3.7M | -$5.5M | -$27.1M | -$24.7M | -$12.5M | -$7.0M | -$5.6M | -$5.4M |
| Working Capital | $5.4M | $6.3M | $7.4M | $9.5M | $33.9M | $32.5M | $22.8M | $15.8M | $11.9M | $11.8M |
Financial Health
| Debt / Equity | 0.18 |
| Current Ratio | 2.72 |
Profitability
| Return on Equity | -10.63% |
| Return on Invested Capital | -7.74% |
| Return on Assets | -6.51% |
| Gross Margin | 61.99% |
| Operating Margin | -3.66% |
| Net Margin | -4.03% |
Related companies: HIND · INFU · MXCT · NYXH · OSUR · PRE · PROF
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of KRMD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks